Immunity, Inflammation and Disease (Aug 2023)

A new CECR1 mutation associated with severe hematological involvement in ADA2 deficiency

  • Delia Nicoară,
  • Cristina Niță,
  • Ana Stanilă,
  • Alexandru Martiniuc,
  • Laura Popa,
  • Eliana Petrescu,
  • Mihaela Bătăneant,
  • Ruxandra Ciofu,
  • Adriana Guriță,
  • Radu Tabăcaru,
  • Ruxandra Ionescu,
  • Laura Groșeanu

DOI
https://doi.org/10.1002/iid3.930
Journal volume & issue
Vol. 11, no. 8
pp. n/a – n/a

Abstract

Read online

Abstract Background The deficiency of adenosine deaminase 2 (DADA2) is an autosomal recessively inherited disease resulting from loss‐of‐function mutations in ADA2, formerly named CECR1 (cat eye syndrome chromosome region, candidate 1) gene. Disease manifestations could be separated into three major phenotypes: inflammatory/vascular, immune dysregulatory, and hematologic; however, most patients presented with significant overlap between these three phenotype groups. Case Presentation We present a case of DADA2 deficiency with disease onset at 3 years old, not recognized till the age of 18 with severe gastrointestinal vasculitis and recurrent episodes of neutropenia associated with a new CECR1 mutation.

Keywords